FDA Corrects Notice on Withdrawal of Approval for Prescription Pain Medications

Summary

The FDA is correcting a notice regarding its proposal to withdraw approval of abbreviated new drug applications for prescription pain medications containing more than 325 milligrams of acetaminophen, and is providing an opportunity for a hearing, following a correction of a previously incorrect statement about the voluntary withdrawal of approval for certain ANDAs.